People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neurona Therapeutics, Inc | — | Biotechnology | Series D+ | $347.5M | $875.0M | 2021 |
| StrideBio, Inc. | — | Biotechnology | Series C | $57.7M | $1.5B | 2021 |
| Ally Therapeutics, Inc. | — | Pharmaceuticals | Series A | $10.0M | $309.7M | 2019 |
Erica Whittaker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Erica Whittaker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Gillis | 1 | 13 |
| Richard Smith | 1 | 11 |
| Michael Martin | 1 | 11 |
| Clay Thorp | 1 | 10 |
| David Goeddel | 1 | 10 |
| Tim Kutzkey | 1 | 7 |
| David Cordo | 1 | 6 |
| Robert Hughes | 1 | 6 |
| Bob More | 1 | 6 |
| Sapan Shah | 1 | 4 |
| Leo - Guthart | 1 | 4 |
| Karen Hong | 1 | 4 |
| Peter Svennilson | 1 | 4 |
| Shaan Gandhi | 1 | 4 |
| Robert Tjian | 1 | 3 |
| James Stutz | 1 | 2 |
| Stewart Parker | 1 | 2 |
| Brad Margus | 1 | 2 |
| Patrick Ritschel | 1 | 2 |
| Mike Dial | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.